| Report ID | 237229 |
| Drug Identification Number | 02511932 |
| Brand name | TARO-BORTEZOMIB |
| Common or Proper name | BORTEZOMIB |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BORTEZOMIB |
| Strength(s) | 2.5MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 2.5mg Vial |
| ATC code | L01XG |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-01 |
| Estimated end date | 2026-03-27 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v28 | 2026-03-02 | French | Compare |
| v27 | 2026-03-02 | English | Compare |
| v26 | 2026-02-23 | French | Compare |
| v25 | 2026-02-23 | English | Compare |
| v24 | 2026-02-06 | French | Compare |
| v23 | 2026-02-06 | English | Compare |
| v22 | 2025-12-05 | French | Compare |
| v21 | 2025-12-05 | English | Compare |
| v20 | 2025-11-11 | French | Compare |
| v19 | 2025-11-11 | English | Compare |
| v18 | 2025-10-06 | French | Compare |
| v17 | 2025-10-06 | English | Compare |
| v16 | 2025-09-15 | French | Compare |
| v15 | 2025-09-15 | English | Compare |
| v14 | 2025-07-07 | French | Compare |
| v13 | 2025-07-07 | English | Compare |
| v12 | 2025-06-04 | French | Compare |
| v11 | 2025-06-04 | English | Compare |
| v10 | 2025-05-20 | French | Compare |
| v9 | 2025-05-20 | English | Compare |